Use of rituximab for fulminant and refractory cases of immune checkpoint inhibitor induced myocyte injury clinically presenting with features of myasthenia gravis: a case series
利妥昔单抗用于治疗暴发性和难治性免疫检查点抑制剂诱发的肌细胞损伤，临床表现为重症肌无力特征：病例系列研究
期刊:European Heart Journal - Case Reports
影响因子:0.8
doi:10.1093/ehjcr/ytaf593
Aziz, Imran Naeem; Gajjar, Rohan; Nandyal, Shreyas; Oredipe, Omotola; Qaddorah, Seba; Amdetsion, Gedion Yilma; Valencia, Javier Gomez; Tottleben, Jonathan
